Detalhe da pesquisa
1.
Adherence during COVID-19: The role of aging and socio-economics status in shaping drug utilization.
J Econ Behav Organ
; 204: 1-14, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36268162
2.
Which valued-based price when patients are heterogeneous?
Health Econ
; 29(8): 923-935, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32537816
3.
Innovation, aging, and health care: Unraveling "silver" from "red" herrings?
Health Econ
; 29 Suppl 1: 3-7, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33146937
4.
Decentralisation and waste flows: A welfare approach.
J Environ Manage
; 217: 969-979, 2018 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29679918
5.
The redistributive effects of copayment in outpatient prescriptions: evidence from Lombardy.
BMC Health Serv Res
; 17(1): 336, 2017 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28482834
6.
A reply to "Who would benefit from average value-based pricing?"
Health Econ
; 30(9): 2284-2286, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34245084
7.
Should I pay for your risky behaviours? Evidence from London.
Prev Med
; 66: 145-58, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24945692
8.
Health care expenditure decisions in the presence of devolution and equalisation grants.
Int J Health Care Finance Econ
; 14(4): 355-68, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25024039
9.
Patients' mobility across borders: a welfare analysis.
Dev Health Econ Public Policy
; 12: 179-200, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24864387
10.
Cross border health care provision: who gains, who loses.
Dev Health Econ Public Policy
; 12: 223-44, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24864389
11.
Timely, Cheap, or Risk-Free? The Effect of Regulation on the Price and Availability of New Drugs.
Pharmacy (Basel)
; 12(2)2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38525730
12.
The illness trap: The impact of disability benefits on willingness to receive HCV treatment.
Econ Hum Biol
; 52: 101352, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38278057
13.
Definition of a prospective payment system to reimburse emergency departments.
BMC Health Serv Res
; 13: 409, 2013 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-24119285
14.
The impact of conventional cost-effectiveness analysis on pricing dynamics in the market of new medicines: a proposed countervailing approach.
Expert Rev Pharmacoecon Outcomes Res
; 23(4): 431-438, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36823030
15.
Is there a bias in patient choices for hospital care? Evidence from three Italian regional health systems.
Health Policy
; 126(7): 668-679, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35508430
16.
Resilient managed competition during pandemics: lessons from the Italian experience during COVID-19.
Health Econ Policy Law
; 17(2): 212-219, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32883395
17.
Waste-to-Energy and recycling: The role of plant ownership and waste mobility.
Waste Manag
; 141: 35-51, 2022 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35092879
18.
Welfare properties of restrictions to health care based on cost effectiveness.
Health Econ
; 20(1): 101-10, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19946884
19.
Beyond price: the effects of non-financial barriers on access to drugs and health outcomes.
Eur J Health Econ
; 22(4): 519-529, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33629208
20.
Strategic costs and preferences revelation in the allocation of resources for health care.
Int J Health Care Finance Econ
; 10(3): 239-56, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20309636